湖北医药学院附属东风医院检验部,复旦大学教育部分子医学重点实验室,广东药学院药科学院药理学教研室;广东药学院药科学院药理学教研室
湖北省教育厅资助项目(B2013105)和国家自然基金资助项目(81102502)
Department of Clinical Laboratory, Dongfen Hospital of Hubei University of Medicine,Key Laboratory of Molecular Medicine, Ministry of Education, Fudan University,Department of Pharmacology, Pharmaceutical College, Guangdong Pharmaceutical University
This work was supported by grants from Department of Education of Hubei Province (B2013105) and The National Natural Science Foundation of China (81102502)
纤溶酶原(PLG)经激活为纤溶酶(PLM)后,除了发挥纤溶和栓溶作用,还广泛参与胚胎发育、组织重构、伤口愈合等生理过程.近年来研究显示:PLM还与炎症、自身免疫、肿瘤和神经变性等存在紧密联系,而且已在细胞表面发现十几种PLG受体(PLGR)、结合蛋白.我们综述了这些受体和结合蛋白的结构、信号通路和致病机制方面的研究进展,从而为进一步理解纤溶系统的功能、发展新的诊疗方法提供思路.
Plasmin (PLM), via activation from plasminogen (PLG), not only exerts fibrinolysis and thrombolysis effects, but also involves in extensive physical processes such as embryonic development, tissue remodeling and wound healing. Moreover, recent studies showed a tough association between PLM with inflammation, autoimmunity, malignancy and neural degeneration. Furthermore, more than ten plasminogen receptors and binding proteins have been discovered on cellular surface. Here, we review the researching progresses on the structures, signal transduction and pathogenic mechanisms of these receptors and binding proteins, so as to provide clues for better understanding on fibrinolysis system and for developing new diagnostic and therapeutic pathways.
陈武,莫炜,王来友.纤溶酶原受体与相关疾病的分子机制[J].生物化学与生物物理进展,2015,42(12):1094-1102
复制生物化学与生物物理进展 ® 2024 版权所有 ICP:京ICP备05023138号-1 京公网安备 11010502031771号